07/17/2013 - 8:57am

A federal court in New York has dismissed a lawsuit alleging that Mylan infringed four of Teva Pharmaceutical Industries' patents when it sought Food and Drug Administration approval for a multiple sclerosis drug.

07/16/2013 - 12:43pm

Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

07/16/2013 - 9:11am

The Food and Drug Administration has approved a generic epilepsy and bipolar disorder drug made by Actavis, the drug maker said.

07/15/2013 - 10:10am

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

07/15/2013 - 8:36am

The Food and Drug Administration has approved a generic opioid painkiller made by Actavis, the drug maker said.

07/15/2013 - 8:24am

A team of scientists at The Wistar Institute has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century, researchers announced Monday.

07/12/2013 - 4:59pm

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

07/12/2013 - 8:56am

The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.

07/12/2013 - 8:45am

Actavis is looking to become the first to market a generic drug for epilepsy, the company said.